Transgenic mice that overexpress angiotensinogen, the sole precursor of angiotensins, in their renal proximal tubular cells develop hypertension, albuminuria, and tubular apoptosis. These pathological changes are due to enhanced generation of reactive oxygen species in the proximal tubule cells. Here, we determined whether overexpression of catalase to decrease oxidant injury in the proximal tubular cells could reverse these abnormalities. Double-transgenic mice specifically overexpressing angiotensinogen and catalase in their renal proximal tubular cells were created by cross-breeding the single transgenics. Non-transgenic littermates served as controls. Overexpression of catalase prevented hypertension, albuminuria, tubulointerstitial fibrosis, and tubular apoptosis in the angiotensinogen transgenic mice. Furthermore, the double transgenics had lower reactive oxygen species generation and reduced profibrotic and apoptotic gene expression in the renal proximal tubular cells. Renal angiotensin converting enzyme-2 expression and urinary angiotensin 1-7 levels were downregulated in the single but normal in the double-transgenic mice. Thus, we suggest that the intrarenal renin-angiotensin system and reactive oxygen species generation have an important role in the development of hypertension and renal injury. Angiotensin II (Ang II) has key roles in hypertension and renal injury leading to end-stage renal disease. Chronic treatment with renin-angiotensin system (RAS) blockers (angiotensin-converting enzyme inhibitors and/or antagonists of angiotensin II (subtype-1) receptor (AT 1 -R)) lowers blood pressure and delays nephropathy progression.
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The degree of glomerulosclerosis, tubulointerstitial fibrosis, and tubular atrophy, determines the rate of decline in renal function. 5 Ang II is involved in these processes and its action is largely mediated through the AT 1 -R that is present throughout the kidney. 6 The AT 1 -R is expressed on both the luminal and basolateral membranes of renal proximal tubular cells (RPTCs). It has been postulated that Ang II produced within the renal proximal tubule (RPT) may be more important than Ang II derived from circulation in inducing kidney damage. Indeed, luminal and tissue Ang II levels are far higher than those in plasma. [7] [8] [9] Intrarenal levels of angiotensinogen (Agt) and Ang II are elevated in hypertension and diabetes, [10] [11] [12] [13] [14] [15] contributing not only to hypertension but also to kidney injury.
The existence of a local intrarenal RAS is now well accepted and all components of the RAS are expressed in RPTCs. [16] [17] [18] [19] [20] [21] [22] Transgenic mice (Tgs) overexpressing rat Agt in their RPTCs are prone to developing hypertension, albuminuria, and renal injury and treatment with RAS blockers normalizes these parameters. 23, 24 Overexpression of Agt increases reactive oxygen species (ROS) production in RPTCs through NADPH oxidase activation, and treatment of Agt-Tgs with apocynin (an inhibitor of NADPH oxidase) attenuates ROS generation and renal injury but not hypertension. 25 Thus, it is unclear whether ROS mediate intrarenal RAS actions on both hypertension development and kidney injury.
The present in vivo study sought to determine whether a mouse model characterized by rat catalase (Cat) overexpression in RPTCs could prevent ROS generation and the development of hypertension, thereby improving the profibrotic and pro-apoptotic effects engendered by upregulated intrarenal RAS.
RESULTS

Tissue-specific expression of rat Agt (rAgt) and rat Cat (rCat) transgenes in Tgs
The rAgt-HA (a sequence encoding amino acid residues 98-106 (YPYDVPDYA) of human influenza virus hemagglutinin-tag) and rCat-HA transgenes were highly expressed in RPTs of adult male Tgs (Figure 1a ) but not in other tissues (liver, spleen, lung, heart, brain and testis; data not shown). Non-Tgs (wild type) did not express transgenes. Immunostaining confirmed the increased expression of Agt ( Figure 1b Consistent with previous studies (23, 24) , an increased urinary albumin/creatinine ratio (ACR) (Figure 3a ) was evident in Agt-Tgs at 20 weeks old as compared with nonTgs and Cat-Tgs. Cat overexpression normalized ACR in Agt/ Cat-Tgs. SBP was significantly higher after 12 weeks in male Agt-Tgs as compared with non-Tgs and Cat-Tgs (Po0.05, increased by 10 to 15 mm Hg) and remained so (Figure 3b ). Overexpression of Cat normalized SBP in Agt/Cat-Tgs (Figures 3b and c) . Wet heart weight/body weight ratios did not differ significantly among different groups (Figure 3d ). Ag-Tg mice showed increased urinary Ang II levels and decreased Ang 1-7 levels compared with non-Tg and Cat-Tg mice, and these changes were normalized in Agt/Cat-Tg mice (Figure 6a and b) . Furthermore, ACE activity in RPT was significantly higher in Agt-Tg mice than in non-Tgs, Cat-Tgs, and Agt/Cat-Tgs (Figure 6c ).
Tubulointerstitial fibrosis
Agt-Tg kidneys showed enhanced expression of collagenous components of extracellular matrix proteins (Figure 7a, B) , immunoreactive collagen type IV (Figure 7b, B) , and monocyte chemotactic protein-1 (MCP-1) (Figure 7c Agt-Tg kidneys also showed higher expression of transforming growth factor-b 1 (TGF-b1) (Figures 8a, B) and plasminogen activator inhibitor-1 (PAI-1) (Figure 8b An increased Bax/Bcl-xL ratio expression is associated with promotion of apoptosis. We next investigated whether this also occurred in RPTs of our Tg mice. Bax mRNA (Figure 9e 
DISCUSSION
This study shows that Cat overexpression in RPTCs effectively prevents hypertension, albuminuria, tubulointerstitial fibrosis, and RPTC apoptosis as well as normalizes RPTC ACE2 expression and urinary Ang 1-7 levels in Agt/ Cat-Tgs as compared with Agt-Tgs. These findings indicate that intrarenal RAS-induced ROS generation and downregulation of ACE2 expression likely have an important role in the development of hypertension, tubulointerstitial fibrosis, and RPTC apoptosis.
In the kidney, Cat is localized predominantly in the cytoplasm of proximal tubules of the superficial cortex. Cat was not detected in the glomeruli, distal tubules, loop of Henle, and collecting ducts. 26 Cat overexpression renders cell more resistant to H 2 O 2 toxicity and oxidant-mediated injury. Transgenic mice overexpressing Cat are protected against myocardial injury in hypertension. 27 However, little is known about whether overexpression of Cat in the kidney could protect against kidney injury.
Consistent with our previous findings, 25 kidney/body weight ratios and glomerular volume did not differ significantly in non-Tgs and Tgs, whereas RPTC volume was significantly higher in Agt-Tgs than non-Tgs and was The heart-to-body weight ratio was measured as the wet weight of heart without blood per body weight. All data are expressed as means ± s.d., N ¼ 8 (*Po0.05; **Po0.01; ***Po0.005; NS not significant).
normalized in Agt/Cat-Tgs. These observations indicate that Agt overexpression and RAS activation stimulate RPTC hypertrophy without affecting glomerular tuft volume.
However, whether intrarenal RAS activation would affect glomerular function such as glomerular filtration rate remains to be determined. Albuminuria (measured by albumin/creatinine ratio, ACR) was detectable after week 16-20 in Agt-Tgs but not in non-Tgs. Cat overexpression in Agt/Cat-Tgs significantly reduced albuminuria at week 20 compared with Agt-Tgs. These observations imply a link between intrarenal RAS activation, ROS, and albuminuria independently of SBP. Indeed, this possibility is supported by our earlier report in which hydralazine (a vasodilator) lowered SBP but not albuminuria in Agt-Tgs. 25 Consistent with previous studies, [23] [24] [25] baseline SBP was significantly higher in Agt-Tgs than in non-Tgs. Cat overexpression in RPTCs of Agt/Cat-Tgs effectively normalized SBP. Interestingly, significantly higher urinary Ang II and lower Ang 1-7 levels were found in Agt-Tgs than in non-Tgs and these changes were normalized in Agt/Cat-Tg mice. Similar trends were detected in ACE activity in RPT. These findings strongly suggest that Ang II increases ACE activity via ROS generation and point toward an important role for the augmented intrarenal Ang II/Ang 1-7 ratio in the development of hypertension.
It is not known how Cat overexpression normalizes hypertension in Agt/Cat-Tgs. The hypothesis that Ang II may downregulate ACE2 gene expression, and subsequently favor hypertension development has received considerable attention. Indeed, Ferrario et al. 28 report that RAS blockade increases kidney cortex ACE2 activity and urinary Ang 1-7 excretion in normotensive Lewis rats. Recent studies by Koka et al. 29 established that ACE and ACE2 levels are low and high, respectively, in normal human kidneys whereas ACE and ACE2 expression is reversed in human hypertensive kidneys. Furthermore, they showed that Ang II upregulated ACE and downregulated ACE2 expression via AT 1 R coupled to extracellular signaling-regulated kinase 1 and 2 (ERK ½) and p38 mitogen-activated protein kinase (p38 MAPK) signaling in vitro. 29 Thus, our findings support the concept that RAS activation induces ROS generation via enhanced NADPH oxidase activity, upregulates ACE activity and downregulates ACE2 expression. Cat overexpression reverses these effects and thereby prevents hypertension development. The underlying mechanisms of ROS upregulation of ACE activity have yet to be defined.
Our data indicate that intrarenal Agt gene expression and ROS generation are important in mediating tubulointerstitial fibrosis and tubular apoptosis. Consistent with previous studies, 24, 25 expression of extracellular matrix proteins such as collagen type IV and pro-fibrotic gene such as TGF-b1 were enhanced in the tubulointerstitium; furthermore, PAI-1 expression in RPTCs of Agt-Tgs was increased. In contrast, the expression of these genes was normalized in Agt/Cat-Tgs. The numbers of TUNEL-positive RPTCs were significantly higher in Agt-Tg than in non-Tgs, which is consistent with previous reports that Ang II induces RPTC apoptosis in vivo. 24, 25, 30, 31 Consistent with the TUNEL assay, Agt-Tgs showed enhanced active caspase-3 expression and activity in their kidneys. These changes were attenuated by overexpression of Cat in concomitant upregulation of Bax mRNA and downregulation of Bcl-xL mRNA expression. Cat overexpression reversed the Bax/Bcl-xL mRNA ratio. An increased Bax/Bcl-xL ratio is consistent with promotion of apoptosis, a mechanism by which RAS and ROS enhance tubular apoptosis in Agt-Tgs.
Based on our observations, we can offer two hypotheses concerning the ways in which intrarenal Ang II induces hypertension and kidney injury. First, intrarenal Ang II might affect SBP via enhanced renal Na þ absorption through direct stimulation of the sodium-potassium adenosine triphosphatase (Na þ -K þ -ATPase) and sodium/hydrogen exchanger-3 (NHE-3) activity in RPTs. 32, 33 Second, because Ang II induces ROS generation and upregulates AT 1 R expression, it would secondarily enhance renal sodium absorption via Na þ -K þ -ATPase activation. For example, Silva and Soares-da-Silva 34 reported that ROS upregulate Na þ -K þ -ATPase activity and gene expression in opossum RPTCs. More recently, Banday et al. 35 reported that oxidative stress-mediated AT 1 R upregulation causes loss of the Na þ -K þ -ATPase biphasic response and enhances Na þ -K þ -ATPase activity in Sprague-Dawley rats. This possibility is supported by our preliminary (unpublished) results that urinary sodium levels were significantly lower in Agt-Tgs than in non-Tgs and were normalized in Agt/Cat-Tgs.
Despite the fact that we previously reported that apocynin, an inhibitor of NADPH oxidase, was ineffective in preventing hypertension in Agt-Tgs, 25 our present study found that overexpression of Cat in RPTCs completely normalized SBP in Agt/Cat-Tgs. A possible explanation for these apparently inconsistent results is that renal Ang II may affect SBP through direct vasoconstriction of glomerular arterioles through the Ang II AT 1 -receptor independently of ROS generation. Apocynin is a weak inhibitor of vascular NADPH oxidase in the absence of myeloperoxidase, which converts apocynin into active apocynin dimer. 36 Our current findings suggest that Cat-overexpression likely alleviates oxidative stress regardless of its source, whereas apocynin could only influence NADPH oxidase-dependent ROS production. Thus, Cat overexpression appears to be more effective than apocynin because NADPH oxidase is not the sole source of ROS in RPTCs of Agt-Tg mice.
Recent studies have shown that chronic hypoxia may be a mechanism of progression of chronic kidney diseases and that the activation of the RAS is intimately involved in chronic hypoxia of the kidney (see recent reviews: Fine and Norman; 37 Nangaku and Fujita
38
). Thus, it is possible that the augmented renal RAS activation in our Agt-Tg mice might induce renal hypoxia via both hemodynamic and nonhemodynamic mechanisms, as postulated by Nangaku and Fujita. 38 The beneficial effects of Cat overexpression are, at least in part, mediated by the amelioration of local hypoxia via degrading hydrogen peroxide to oxygen and water in RPTCs. However, whether activation of the intrarenal RAS may directly affect RPTC hypoxia remains to be determined. Finally, since chronic hypoxia in the kidney is an ideal therapeutic target and Cat expression might alleviate cellular hypoxia, our findings suggest that the activation of Cat expression in RPTCs by novel drugs may offer novel therapeutics for retarding or preventing chronic kidney disease.
In summary, our study indicates an important role for intrarenal RAS and ROS in hypertension, albuminuria, interstitial fibrosis and RPTC apoptosis observed in AgtTgs. The Agt/Cat-Tg model may be useful for studying the mechanism (s) of Ang II action on ROS generation and kidney-dependent hypertension. Our data suggest that selective inactivation of renal ROS generation and upregulation of ACE2 and Cat may provide novel therapeutic targets for preventing hypertension and reversing nephropathy in hypertension and renal disease.
MATERIALS AND METHODS
The pKAP2 plasmid contains the kidney androgen-regulated promoter (KAP), which is responsive to testosterone stimulation, was obtained from Dr Curt D Sigmund (University of Iowa, Iowa, IA, USA) and has been described elsewhere. Biolabs (Pickering, ON, Canada) and Chemicon International (Temecula, CA, USA), respectively. Rabbit anti-rat Agt antibodies were generated in our laboratory (JSDC). 21 These antibodies are specific for intact rat and mouse Agt (that is, 55-62 kDa Agt) and do not cross-react with pituitary hormone preparations or other rat or mouse plasma proteins. 21 Oligonucleotides were procured from Invitrogen (Burlington, ON, Canada). Restriction and modifying enzymes were purchased from either Invitrogen or La Roche Biochemicals (Laval, QC, Canada).
Generation of KAP2-Agt/Cat-Tgs
The creation of Tgs overexpressing rAgt or rCat in their RPTCs has been described previously. 14, 23 Briefly, cDNA encoding full-length rAgt or rCAT fused with HA and terminating codon at the 3 0 end (NotI site flanked at both 5 0 -and 3 0 -terminali) were inserted into pKAP2 plasmid at the NotI site of exon II of human Agt gene. The isolated KAP2-rAgt or KAP2-rCAT transgene was then microinjected into 1-cell fertilized mouse embryos using a standard procedure. The positive Tg founders were then crossed with wild type C57Bl6 mice for F1 generation. Breeding was continued until homozygous F3 and F4 Tg mice were obtained. Agt/Cat Tgs were created by cross-breeding the Agt-Tgs (no. 388) with Cat-Tgs (no. 688) (C57Bl6 background) and by continuing breeding until homozygous Agt/Cat-Tgs were obtained.
Physiological studies
Unless otherwise noted, we used male Tgs aged 10-20 weeks at data collection. Non-Tg littermates served as controls. All animals received standard mouse chow and water ad libitum. Animal care and procedures were approved by the CRCHUM's Animal Care Committee. Systolic blood pressure (SBP) was monitored with a blood pressure-2000 tail-cuff pressure machine (Visitech Systems, Apex, NC, USA) 15, [23] [24] [25] in the morning, at least 2-3 times a week, for 10 weeks. The mice were trained in the procedure for at least 15-20 min per day for 5 days before the first SBP measurements. SBP values represent the mean ± s.d. of 2-3 determinations per week per animal per group (N ¼ 8 animals per group). All animals were euthanized at age 20 weeks. Twenty-four hours before euthanasia, they were RT-qPCR of TGF-b1 (e) and PAI-1 (f) mRNA. TGF-b1, PAI-1 and b-actin mRNAs were run simultaneously in the same RT-qPCR assay. TGF-b1 and PAI-1 mRNA levels were normalized by corresponding b-actin mRNA levels. mRNA levels in non-Tg were considered as 100%. All data are expressed as means±s.d., N ¼ 8 (*Po0.05; ***Po0.005). PAI-1, plasminogen activator inhibitor-1.
housed individually in metabolic cages. Body weight was recorded. Urine was collected and assayed for albumin and creatinine (ELISA, Albuwell and Creatinine Companion, Exocell, Philadelphia, PA, USA). [23] [24] [25] Both kidneys and hearts were removed immediately after euthanasia. The decapsulated kidneys and wet hearts were weighed. The left kidneys were processed for histology and apoptosis study, and the right kidneys were used for isolation of renal proximal tubules (RPTs) by Percoll gradient. [23] [24] [25] Histological studies Kidney sections (4-5 sections, 3-4 mm thick, per kidney) from eight animals per group were stained with hematoxylin and eosin or Masson's trichrome stain and analyzed visually under a light microscope by two investigators blinded to the treatments. [23] [24] [25] Masson's trichrome-stained images were quantified by NIH ImageJ software (http://rsb.info.nih.gov/ij/).
The mean glomerular volumes on 30 random glomerular sections per mouse were determined by the method of Weibel 41 with the Motics Images Plus 2.0 image analysis software (Motic, Richmond, BC, Canada). RPTC volume was measured from 100 RPTCs per mouse with the same software. Outer cortical RPTs with similar cross-sectional views and clear nuclear structure were selected. The mean cell volume was estimated by the Nucleator method. 42 Immunohistochemical staining was performed according to the standard avidin-biotin-peroxidase complex method (ABC Staining System, Santa Cruz Biotechnologies, Santa Cruz, CA, USA). [23] [24] [25] Immunostaining with nonimmune normal rabbit serum (displayed no immunostaining) for putative genes in both non-Tg and Tg mouse kidneys served as controls (not shown). The percentage of apoptotic RPTCs (TUNEL kit, Roche Diagnostics, Laval, QC, Canada) was estimated semi-quantitatively as previously described. Urinary Ang II and Ang 1-7 measurement and ACE activity assay Mouse urine samples (180 ml per animal) were initially purified by C18 Sep-Pak columns (Waters Corporation, MA USA) and then extracted with an extraction kit (Bachem Americas, Torrance, CA USA) according to the recommended number III protocol. The residues were then resuspended in 120 ml of EIA buffer solution (supplied by Bachem Americas) and aliquots (50 ml each) were used for Ang II or Ang 1-7 measurement by respective specific ELISA (Bachem Americas). ACE activity was quantified by the cleavage of the substrate hippuryl-L-histidyl-L-leucine (HHL, Sigma-Aldrich Canada) followed by labeling with o-phthaldialdehyde (OPA, Sigma-Aldrich Canada) according to the method described by Dean et al. 43 with slight modifications. Briefly, B40 mg of proteins (RPT extracts) were diluted in sodium borate buffer (0.4 mol/l boric acid, 0.3 mol/l NaCl, pH8.3) (final volume 50 ml) and incubated for 1 h at 371C in the presence or absence of 100 mmol/l perindopril (an ACE inhibitor). The reaction was stopped by the addition of 0.34 mol/l NaOH (final concentration 0.28 mol/l) followed by labeling with 40 ml of 20 mg/ml OPA. After incubation for 10 min, 100 ml of 3 mol/l HCl was added and the measurements of fluorescence were carried at wavelengths of 360 nm excitation and 530 nm emission. The values of ACE activity were calculated by substraction of perindopril-containing tubes from those without perindopril. All values were normalized by the protein concentrations and expressed as the relative light unit emission per mg protein.
ROS generation, NADPH oxidase and caspase-3 activity assays ROS production in the kidney was assessed by ROS generation in freshly isolated RPTs by the lucigenin method 14, 15, 24, 25, 44 and NADPH oxidase activity. 25 Oxidative stress in RPTCs in vivo was assessed by standard immunohistochemical staining for heme oxygenase 1 (HO-1, an oxidative stress-inducible gene that confers cellular oxidative stress in vivo). 45 Briefly, RPTs were washed in modified Krebs buffer containing NaCl (130 mmol/l), KCl (5 mmol/l), MgCl 2 (1 mmol/l), CaCl 2 (1.5 mmol/l), K 2 HPO 4 (1 mmol/l) and Hepes (20 mmol/l), pH 7.4, and resuspended in 900 ml of Krebs buffer supplemented with 1 mg/ ml bovine serum albumin (BSA). The cell suspension was transferred to plastic tubes and ROS production was assessed in a luminometer (LB 9507; Berthold, Wildbad, Germany). Measurement began with an injection of 100 ml lucigenin (final concentration 5 Â 10 À4 M). Photon emissions were counted every 1 min for up to 20 min. Peak emissions at 10 min were recorded from each group for comparison. Modified Krebs buffer served as a control (blank). Solutions containing lucigenin without RPTs did not display any significant interference in the lucigenin assay. ROS production in RPTs was normalized with protein concentration and expressed as relative light units per min per mg protein.
NADPH oxidase activity was measured by a luminescence assay. 25, 46, 47 Briefly, RPTs were homogenized in lysis buffer and assayed in 50 mmol/l phosphate buffer, pH. 7.0, containing 1 mmol/l EGTA, 150 mmol/l sucrose, 5 mM lucigenin and 100 mM NADPH (final volume, 0.9 ml). The reaction was started after the addition of 100 ml (B100 mg) of homogenate protein. No activity was detected in the absence of NADPH.
Caspase-3 activity was assayed on frozen (À801C) RPTs with caspase-3 assay kits (BD Bioscience Pharmingen, Mississauga, ON, Canada), as described previously.
24,25
Western blotting and real time-quantitative polymerase chain reaction (RT-qPCR) assays for gene expression Western blotting for ACE, ACE2, TGF-b1, and PAI-1 was performed as described elsewhere using RPT lysates. 14, 15, 24, 25 The membrane was then blotted with primary anti-ACE, ACE2, TGF-b1, or PAI-1 antibody and then re-blotted with anti-b-actin monoclonal antibodies and chemiluminescent developing reagent (Roche Biochemicals). The relative densities of ACE, ACE2, TGF-b1, PAI-1, and b-actin bands were quantified by computerized laser densitometry (ImageQuant software (version 5.1), Molecular Dynamics, Sunnyvale, CA, USA).
ACE, ACE2, collagen type IV, TGF-b1, PAI-1, MCP-1, Bax, Bcl-xL, and b-actin mRNA expression in RPTs was quantified by RT-qPCR with forward and reverse primers corresponding to the respective genes (Table 1) according to the methods as described previously. 14, 15, 24, 25 Statistical analysis Data are expressed as mean±s.d. The data are analyzed by one-way ANOVA and the Bonferroni test. P-values o0.05 were considered significant.
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